therapeutic 1,336 words KG: NAD+
Contents

NAD+ Precursor Therapy for Neurodegenerative Diseases

💊 Therapeutic Info
NameNAD+
Key Genes/ProteinsAMPK, CD38, CX43
Related DiseasesAlzheimer disease
Related Pathwayscellular senescence, epigenetic clocks
Linked Hypotheses22 hypotheses

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (52)

TFAM overexpression creates mitochondrial donor-recipient gr
Score: 0.73
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.71
HDAC3-Selective Inhibition for Clock Reset
Score: 0.71
Autophagosome Maturation Checkpoint Control
Score: 0.71
Orexin-Microglia Modulation Therapy
Score: 0.71
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.71
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.70
Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration
Score: 0.70
Lysosomal Calcium Channel Modulation Therapy
Score: 0.70
Complement C1q Mimetic Decoy Therapy
Score: 0.69
Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.69
Ganglioside Rebalancing Therapy
Score: 0.69
Hypocretin-Neurogenesis Coupling Therapy
Score: 0.69
R-Loop Resolution Enhancement Therapy
Score: 0.68
Excitatory Neuron Vulnerability via SLC17A7 Downregulation
Score: 0.67
Mitochondrial-Lysosomal Contact Site Engineering
Score: 0.67
Arginine Methylation Enhancement Therapy
Score: 0.65
Glial Glycocalyx Remodeling Therapy
Score: 0.65
HCN1-Mediated Resonance Frequency Stabilization Therapy
Score: 0.65
Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m
Score: 0.62
← Prevpg 2/3Next →

Related Analyses (29)

Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived

Related Experiments (23)

Germfree mouse colonocyte energy metabolism analysis
validation · proposed · Score: 0.90
NAD depletion effects on monocyte/macrophage differentiation
exploratory · proposed · Score: 0.90
FK866 treatment in DSS-induced colitis mouse model
validation · proposed · Score: 0.90
FK866 in azoxymethane/DSS colitis-associated cancer model
validation · proposed · Score: 0.85
Sirtuin Pathway Dysfunction Validation in Parkinson's Diseas
clinical · proposed · Score: 0.40

See Also (5)

ATP P2X3 Receptor Neurons
cell · KG edge: causes
AMPK (AMP-Activated Protein Kinase)
entity · KG edge: activates
CD38 Molecule (CD38)
gene · KG edge: degrades
APP Gene Dosage Reduction Therapy for Down Syndrome
idea · KG edge: inhibits
Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: inhibits

Knowledge Graph (12 edges)

NAD+ activates SIRT1
AMPK contributes_to NAD+
NAD+ regulates SIRT1
NAD+ modulates SIRT1
CD38 depletes NAD+
PARP degrades NAD+
SIRT degrades NAD+
NAD+ protects_against BLOOD-BRAIN BARRIER DAMAGE
NAD+ associated_with Cellular Processes
NAD+ modulates inflammation

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.